| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 10.939 | 116.568 | 190.858 | 194.261 | 135.033 | 124.796 | 99.396 | 86.228 | 35.850 |
| Total Income - EUR | - | 11.384 | 118.546 | 193.292 | 198.192 | 139.708 | 124.842 | 99.351 | 86.228 | 35.850 |
| Total Expenses - EUR | - | 5.517 | 115.523 | 193.397 | 193.068 | 134.045 | 129.655 | 112.709 | 96.594 | 40.871 |
| Gross Profit/Loss - EUR | - | 5.867 | 3.024 | -105 | 5.124 | 5.663 | -4.814 | -13.358 | -10.366 | -5.021 |
| Net Profit/Loss - EUR | - | 5.543 | 1.840 | -2.031 | 3.181 | 4.623 | -5.980 | -14.353 | -11.228 | -5.110 |
| Employees | - | 0 | 1 | 2 | 3 | 3 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Şerb Ralsilv Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 140 | 88 | 6.670 | 4.856 | 5.008 | 2.875 | 1.123 | 807 | 626 |
| Current Assets | - | 6.725 | 17.939 | 25.406 | 30.267 | 36.097 | 22.792 | 18.546 | 17.841 | 11.110 |
| Inventories | - | 3.453 | 12.406 | 14.655 | 14.963 | 11.446 | 15.453 | 15.524 | 13.198 | 9.553 |
| Receivables | - | 0 | 79 | 3.322 | 612 | 64 | 55 | 131 | 342 | 70 |
| Cash | - | 3.272 | 5.454 | 7.429 | 14.691 | 24.587 | 7.284 | 2.891 | 4.301 | 1.487 |
| Shareholders Funds | - | 5.588 | 7.333 | 5.168 | 8.249 | 12.715 | -5.931 | -20.303 | -31.469 | -36.404 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.277 | 10.693 | 26.908 | 26.874 | 28.390 | 31.598 | 39.971 | 50.117 | 48.139 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Şerb Ralsilv Med Srl